With very few adjuvants currently being used in marketed human vaccines, a critical need
exists for novel immunopotentiators and delivery vehicles capable of eliciting humoral, cellular …

The effect of adsorption onto aluminum salt adjuvants on the structure and stability of three
model protein antigens was studied using fluorescence and Fourier transform infrared …

Tumor-associated autoantibodies (AAbs) have been described in patients with lung cancer,
and the EarlyCDT®-Lung test that measures such AAbs is available as an aid for the early …

Objectives EarlyCDT ® -Lung may enhance detection of early stage lung cancer by aiding
physicians in assessing high-risk patients through measurement of biological markers (ie, …

Angiogenesis has long been a desired therapeutic approach to improve clinical outcomes
of conditions typified by ischemia. Vascular endothelial growth factor (VEGF) has …

Introduction The incidence of pulmonary nodules is increasing with the movement toward
screening for lung cancer by low-dose computed tomography. Given the large number of …

Anthrax remains a serious threat worldwide as a bioterror agent. A second-generation anthrax
vaccine currently under clinical evaluation consists of a recombinant Protective Antigen (…

Excipients for protein-based vaccines are currently identified by evaluating the stability of
the protein in solution. In most cases, however, the protein is adsorbed to the surface of an …

We describe an alternate approach for studying protein structure using the detection of
ultraviolet (UV) absorbance peak shifts of aromatic amino acid side chains induced by the …

Background Further signal stratification for the EarlyCDT®-Lung test should facilitate
interpretation of the test, leading to more precise interventions for particular patients. Methods …